07 - Plastic and Reconstructive / 07.03 - DENTAL IMPLANTS / 07.03.03 - Endosseous Implant

07.03.03.05 - Graft Material 0.5ml-<1.0ml

13 devices · 9 sponsors

March 2027 window closes in 92 days

Median benefit

$293.00

Range

$293–293

Comparator candidates

Code	Device · sponsor	Benefit	Tier 1 comparator?
ER378	Bicon SynthoGraft Pure Phase Beta-Tricalcium Phosphate, 0.5 g EMERGO ASIA-PACIFIC PTY. LIMITED	$293.00	eligible
FV013	OSSIX Bone DENTSPLY SIRONA PTY LIMITED	$293.00	eligible
GI007	Bio-Oss Pen GEISTLICH PHARMA AUSTRALIA PTY LTD	$293.00	eligible
GI032	Bio-Oss GEISTLICH PHARMA AUSTRALIA PTY LTD	$293.00	eligible
HD023	BioHorizons MinerOss XP Henry Schein-Halas Pty Ltd	$293.00	eligible
IF002	Bioresorb Macro Pore Implant Direct Oceania Pty Limited	$293.00	eligible
MV021	BVital GENOSS Granules MORE GROUP PTY LTD	$293.00	eligible
NW006	Endobon Xenograft Granules ZIMVIE AUSTRALIA PTY LTD	$293.00	eligible
SB006	Straumann Bone Ceramic STRAUMANN PTY LTD	$293.00	eligible
SB021	cerabone STRAUMANN PTY LTD	$293.00	eligible
SB036	Cerabone Plus 0.5 ml volume STRAUMANN PTY LTD	$293.00	eligible
UK036	InterOss Vial The Trustee for Giorgios and Katarina Loizou Family Trust	$293.00	eligible
UK037	InterOss Syringe The Trustee for Giorgios and Katarina Loizou Family Trust	$293.00	eligible

13 device(s).

Tier pre-screener

Indicative only — pathway choice is the sponsor's responsibility.

TGA class of your device Well-established technology? Listing in this existing grouping? Interchangeable with a comparator here?

4-year benefit estimate

For the HPP utilisation section — arithmetic on your inputs.

Benefit $ Units/yr (low) Units/yr (high)

Year	Low	High
4-year total

Data: current Prescribed List · Calculations are based on published government data and figures you enter — a lookup and arithmetic tool, not regulatory or billing advice · Not an official government service.